Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis. [electronic resource]
Producer: 20020110Description: 102-10 p. digitalISSN:- 0165-5728
- Adjuvants, Immunologic -- administration & dosage
- Adult
- Antigens, CD -- analysis
- Antigens, CD1 -- analysis
- B7-2 Antigen
- Cell Differentiation -- drug effects
- Dendritic Cells -- chemistry
- Drug Synergism
- Female
- Flow Cytometry
- Glatiramer Acetate
- Humans
- Immunophenotyping
- Interferon-beta -- administration & dosage
- Interleukin-10 -- analysis
- Interleukin-12 -- analysis
- Male
- Membrane Glycoproteins -- analysis
- Middle Aged
- Multiple Sclerosis, Chronic Progressive -- drug therapy
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Peptides -- administration & dosage
- Receptors, Interleukin-3 -- analysis
- Th2 Cells -- cytology
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.